Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding
The United States Congress has officially passed a comprehensive funding bill for the Department of Health and Human Services (HHS)…
disease management
Amara Maple Beyond the Scale: How GLP-1 Receptor Agonists are Redefining Metabolic Health Across Diverse Patient Populations
The clinical landscape of metabolic medicine is undergoing a seismic shift as glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed to…
High Body Mass Index and Hypertension Identified as Direct Causal Factors in the Development of Vascular-Related Dementia
A landmark study published in The Journal of Clinical Endocrinology & Metabolism (JCEM) has provided definitive evidence linking obesity and…
Advancing Endocrine Science: A Deep Dive into the Endocrine Society’s Strategic Initiatives for Presenting Publishing and Professional Mentorship
The Endocrine Society, a premier global organization representing over 18,000 professionals in the field of hormone research and clinical endocrinology,…
Endocrine Society Announces 2026 Laureate Award Winners and New Clinical Advancements in Thyroid Treatment and Global Research Infrastructure
The Endocrine Society has officially launched its January 2026 programming, marking the beginning of the year with a comprehensive tribute…
Oral Semaglutide 25 mg Receives FDA Approval for Chronic Weight Management Marking a New Era in Metabolic Health
The landscape of metabolic medicine underwent a significant transformation in early January 2026 as the 25 mg oral formulation of…
Endocrine Society Launches Rare Endocrine Disease Fellows Program to Bridge Critical Gaps in Specialist Education and Patient Care
The Endocrine Society has officially announced the commencement of its Rare Endocrine Disease (RED) Fellows Program, a specialized educational initiative…
Midlife Insulin Levels Linked to Timing and Duration of Menopausal Vasomotor Symptoms According to New University of Victoria Study
Research conducted at the University of Victoria (UVic) has established a significant correlation between a woman’s insulin levels during midlife…
The Evolving Landscape of GLP-1 Receptor Agonists From Weight Loss Revolution to Addiction Treatment and Rare Clinical Risks
The pharmaceutical landscape is currently witnessing a transformative era defined by the meteoric rise of glucagon-like peptide-1 receptor agonists (GLP-1RAs).…
Both Ends of the Spectrum: Talking Obesity Science with Samuel Klein, MD
The Endocrine Society has officially announced that Samuel Klein, MD, the William H. Danforth Professor of Medicine and Nutritional Science…
